ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
25.20
+2.32 (10.14%)
At close: Jan 22, 2026, 4:00 PM EST
25.20
0.00 (0.00%)
Pre-market: Jan 23, 2026, 4:45 AM EST
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $1.04 billion as of January 23, 2026. Its market cap has increased by 18.06% in one year.
Market Cap
1.04B
Enterprise Value
740.08M
1-Year Change
18.06%
Ranking
Category
Stock Price
$25.20
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $1.04B, an increase of 80.85%. That is a compound annual growth rate of 34.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 1.04B | 25.25% |
| Dec 31, 2025 | 830.58M | -7.48% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zenas BioPharma | 1.10B |
| Palvella Therapeutics | 1.09B |
| Iovance Biotherapeutics | 1.07B |
| Theravance Biopharma | 1.05B |
| ARS Pharmaceuticals | 1.04B |
| GH Research | 1.04B |
| Annexon | 1.04B |
| Nanobiotix | 1.03B |